Compare IND. SWIFT with Orchid Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IND. SWIFT vs ORCHID PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IND. SWIFT ORCHID PHARMA IND. SWIFT/
ORCHID PHARMA
 
P/E (TTM) x -3.2 -17.1 - View Chart
P/BV x - 2.5 - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 IND. SWIFT   ORCHID PHARMA
EQUITY SHARE DATA
    IND. SWIFT
Mar-21
ORCHID PHARMA
Mar-21
IND. SWIFT/
ORCHID PHARMA
5-Yr Chart
Click to enlarge
High Rs52,465 0.2%   
Low Rs218 10.3%   
Sales per share (Unadj.) Rs65.7110.3 59.6%  
Earnings per share (Unadj.) Rs-5.5-28.5 19.3%  
Cash flow per share (Unadj.) Rs0.5-1.9 -28.6%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs-128.4159.9 -80.2%  
Shares outstanding (eoy) m54.1640.82 132.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.111.3 0.5%   
Avg P/E ratio x-0.6-43.5 1.4%  
P/CF ratio (eoy) x6.4-665.6 -1.0%  
Price / Book Value ratio x07.8 -0.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m18450,677 0.4%   
No. of employees `000NANA-   
Total wages/salary Rs m512671 76.3%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,5614,501 79.1%  
Other income Rs m152152 100.0%   
Total revenues Rs m3,7134,653 79.8%   
Gross profit Rs m402294 136.8%  
Depreciation Rs m3271,089 30.0%   
Interest Rs m522522 99.9%   
Profit before tax Rs m-295-1,165 25.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m30-   
Profit after tax Rs m-298-1,165 25.6%  
Gross profit margin %11.36.5 172.9%  
Effective tax rate %-1.10-   
Net profit margin %-8.4-25.9 32.3%  
BALANCE SHEET DATA
Current assets Rs m2,6525,499 48.2%   
Current liabilities Rs m7,0621,421 497.0%   
Net working cap to sales %-123.990.6 -136.7%  
Current ratio x0.43.9 9.7%  
Inventory Days Days15320 769.2%  
Debtors Days Days1,1071,101 100.5%  
Net fixed assets Rs m4,0646,874 59.1%   
Share capital Rs m108408 26.5%   
"Free" reserves Rs m-7,0606,121 -115.3%   
Net worth Rs m-6,9526,529 -106.5%   
Long term debt Rs m6,4424,275 150.7%   
Total assets Rs m6,71612,373 54.3%  
Interest coverage x0.4-1.2 -35.3%   
Debt to equity ratio x-0.90.7 -141.5%  
Sales to assets ratio x0.50.4 145.8%   
Return on assets %3.3-5.2 -64.0%  
Return on equity %4.3-17.8 -24.0%  
Return on capital %-44.5-6.0 747.2%  
Exports to sales %74.288.1 84.2%   
Imports to sales %5.037.3 13.3%   
Exports (fob) Rs m2,6433,966 66.6%   
Imports (cif) Rs m1761,677 10.5%   
Fx inflow Rs m2,6823,966 67.6%   
Fx outflow Rs m2601,729 15.0%   
Net fx Rs m2,4222,237 108.3%   
CASH FLOW
From Operations Rs m772236 327.5%  
From Investments Rs m-167672 -24.9%  
From Financial Activity Rs m-483-1,650 29.3%  
Net Cashflow Rs m122-742 -16.5%  

Share Holding

Indian Promoters % 55.6 90.0 61.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 5.2 -  
FIIs % 0.0 1.8 -  
ADR/GDR % 0.0 0.0 -  
Free float % 44.5 10.0 444.5%  
Shareholders   13,596 33,533 40.5%  
Pledged promoter(s) holding % 73.5 32.7 224.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IND. SWIFT With:   SUN PHARMA    LUPIN    CIPLA    DR. REDDYS LAB    AUROBINDO PHARMA    



Today's Market

Sensex Sheds 427 Points, Nifty Ends Near 17,600; Bajaj Finserv, Tata Steel & Tech Mahindra Top Losers(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views on News

Why Did Orchid Pharma Shares Plunge 10% Today? (Views On News)

Jun 25, 2021

Orchid Pharma shares plunge 10% as company fixes OFS price at 72% discount.

Orchid Pharma Shares Zoom 7,700% in Seven Months. More Gains Ahead? (Views On News)

Jun 3, 2021

Here's why Orchid Pharma shares have rallied 7,700% in seven months.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

More Views on News

Most Popular

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

IND. SWIFT SHARE PRICE


Jan 21, 2022 03:35 PM

TRACK IND. SWIFT

  • Track your investment in IND. SWIFT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

IND. SWIFT - SUN PHARMA COMPARISON

COMPARE IND. SWIFT WITH

MARKET STATS